Global Impact of COVID-19 on Stroke Care and IV Thrombolysis.
No Thumbnail Available
Identifiers
Date
2021-03-25
Authors
Nogueira, Raul G
Qureshi, Muhammad M
Abdalkader, Mohamad
Martins, Sheila Ouriques
Yamagami, Hiroshi
Qiu, Zhongming
Mansour, Ossama Yassin
Sathya, Anvitha
Czlonkowska, Anna
Tsivgoulis, Georgios
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
To measure the global impact of COVID-19 pandemic on volumes of IV thrombolysis (IVT), IVT transfers, and stroke hospitalizations over 4 months at the height of the pandemic (March 1 to June 30, 2020) compared with 2 control 4-month periods. We conducted a cross-sectional, observational, retrospective study across 6 continents, 70 countries, and 457 stroke centers. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. There were 91,373 stroke admissions in the 4 months immediately before compared to 80,894 admissions during the pandemic months, representing an 11.5% (95% confidence interval [CI] -11.7 to -11.3, p The COVID-19 pandemic was associated with a global decline in the volume of stroke hospitalizations, IVT, and interfacility IVT transfers. Primary stroke centers and centers with higher COVID-19 inpatient volumes experienced steeper declines. Recovery of stroke hospitalization was noted in the later pandemic months.
Description
MeSH Terms
COVID-19
Cross-Sectional Studies
Hospitalization
Humans
Pandemics
Retrospective Studies
SARS-CoV-2
Stroke
Thrombolytic Therapy
Cross-Sectional Studies
Hospitalization
Humans
Pandemics
Retrospective Studies
SARS-CoV-2
Stroke
Thrombolytic Therapy